Shares of Innoviva (NASDAQ:INVA), a biotechnology royalty company that develops respiratory therapeutics and is perhaps best known as GlaxoSmithKline’s (NYSE:GSK) development partner for its multiple next-generation COPD and asthma products, fell as much as 11% on Thursday. The reason behind Innoviva’s bad day can be traced to a proxy battle with activist hedge....More>>>
Warren Buffett-led Berkshire Hathaway stock could provide similar diversification as S&P 500 ETF with even better results.
Many investors prefer a diversified low-risk portfolio over theriskier strategy of stock-picking. The SPDR S&P 500 ETF Trust (NYSEMKT:SPY) is very popular for this purpose since it follows the S&P 500 index of 500 large cap companies listed on the NYSE....More>>>
Below is my list of the top gold & silver mining stock takeover targets. None of them are producers, but they all have very lucrative properties. Plus, they are all undervalued. Most of them have very advanced projects.
Investing in biotech and pharmaceuticals is always a bit of a wild card. The industry is often at the mercy of government regulators, and a clinical trial can always present unexpected challenges. When biotech and pharma stocks hit it big, however, its big news that often yields big returns. A lesser promoted biotech sector is the medical devices arena, which is hardly as sexy and....More>>>
Clearly with St. Patrick’s Day falling on Friday, the volume of trading dropped as Wall Street enjoyed the festivities. However, once again the market continued the inexorable climb higher this past week. For the first time this year, the insider buying volume looked to be much closer to the selling in share count, though insider sellers still seemed to dominate in the dollar amount. Either....More>>>
BlackBerry (NASDAQ:BBRY) is at it again. Another quarter, another smartphone device. BBRY unveiled a new device called KEYone. The device is designed and manufactured by TCL, as per the previous agreement with the company months ago.
The KEYone is actually a good looking device. The all aluminum solid body has a very premium feel. The 4.5-inch LCD has a 3:2 aspect ratio, and resolution of....More>>>
Simon Property Group (NYSE:SPG) and General Growth Properties (NYSE:GGP), the country’s two biggest mall owners, are getting understandably tired of stores in their properties closing and of the subsequent vacancies. So they couldn’t have been thrilled when Aeropostale (NYSE:ARO), a large teen-apparel retailer based primarily in malls, filed for bankruptcy in May.
Transocean (NYSE:RIG), like its offshore drilling peers, has lost a lot of value on the stock market since the oil crash began. More specifically, Transocean has lost close to 80% of market cap since the start of oil price crash in June 2014, but I think that the downside is limited going forward.
In fact, on analysing the fundamentals of the company, Transocean seems to be the best bet in....More>>>
Late Tuesday, Gilead Sciences (GILD) won a court ruling in its battle with Merck (MRK) over the intellectual property rights behind its blockbuster hepatitis-C drugs Harvoni and Sovaldi. Gabelli’s Jing He stands by her contention that Gilead is “the most undervalued stock” in biotech:
Gilead Sciences CEO John Milligan Victor J. Blue/Bloomberg News
This article is reprinted by permission from NextAvenue.org.
Money is the top cause of stress in the U.S., the American Psychological Association reports, and the leading driver of stress in the workplace, according to studies by the National Business Group on Health, Aon Hewitt, PwC and